Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Münster AML-study group

In pediatric acute myeloid leukemia (AML), cytogenetic abnormalities are strong indicators of prognosis. Some recurrent cytogenetic abnormalities, such as t(8;16)(p11;p13), are so rare that collaborative studies are required to define their prognostic impact. We collected the clinical characteristic...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Blood
Autors principals: Coenen, Eva A., Zwaan, C. Michel, Reinhardt, Dirk, Harrison, Christine J., Haas, Oskar A., de Haas, Valerie, Mihál, Vladimir, De Moerloose, Barbara, Jeison, Marta, Rubnitz, Jeffrey E., Tomizawa, Daisuke, Johnston, Donna, Alonzo, Todd A., Hasle, Henrik, Auvrignon, Anne, Dworzak, Michael, Pession, Andrea, van der Velden, Vincent H. J., Swansbury, John, Wong, Kit-fai, Terui, Kiminori, Savasan, Sureyya, Winstanley, Mark, Vaitkeviciene, Goda, Zimmermann, Martin, Pieters, Rob, van den Heuvel-Eibrink, Marry M.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2013
Matèries:
Myeloid Neoplasia
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4314534/
https://ncbi.nlm.nih.gov/pubmed/23974201
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-02-485524
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars